Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-839-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation (OECD TG 429): sensitising
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14-11-2017 to 13-12-2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2010
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: obtained from sponsor, Batch no. 2642704.
- Test facility number 209144/A
- Expiration date of the lot/batch: 28-02-2018 and extended to 28-12-2018 (30-03-2018)
- Purity test date: 20-09-2017
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: at room tempersture.
OTHER SPECIFICS: UVCB - Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: Young adult animals approximately 11 weeks old
- Weight at study initiation: 20.4 to 24.2 g
- Housing: up to 5 animals /polycarbonate cage, Makrolon MIII type; height 18 cm. Bedding: sterilized sawdust (Lignocel S 8-15, JRS - J.Rettenmaier & Söhne GmbH + CO. KG, Rosenberg, Germany)
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days
- Indication of any skin lesions: before the initiation of dosing, a health inspection was performed and any assigned animal considered unsuitable for use in the study were replaced by alternate animals obtained from the same shipment and maintained under the same environmental conditions.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 24°C
- Humidity (%): 40-70%
- Air changes (per hr): At least 10 air changes per hour
- Photoperiod (hrs dark / hrs light): 12-hours light and 12-hours dark
IN-LIFE DATES: not specified - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Pre-screen test: 50 and 100% (w/w)
Second pre-screen test: 2, 5, 10 and 25% (w/w)
Main test: 0, 1, 2 and 5% (w/w) - No. of animals per dose:
- 5
- Details on study design:
- PRE-SCREEN TESTS:
- Irritation: erythema and eschar formation observations were performed once daily on days 1-6 (on days 1-3 within 1 hour after dosing).
- Systemic toxicity: observations were performed once daily on days 1-6 (on days 1-3 between 3 and 4 hours after dosing).
- Ear thickness measurements: ear thickness measurements were conducted using a digital thickness gauge (Kroeplin C110T-K) prior to dosing on days 1 and 3, and on day 6.
- Erythema scores:
0 No erythema
1 Very slight erythema (barely perceptible)
2 Well-defined erythema
3 Moderate to severe erythema (beet redness) to slight eschar formation (injuries in depth)
4 Severe erythema (beet redness) to eschar formation preventing grading of erythema
MAIN STUDY
In the main study, three experimental groups of five female CBA/J mice were topically treated with 25µL/ear test item concentrations on three consecutive days, by open application on the ears. Five vehicle control animals were similarly treated, but with the vehicle alone (Aceton/Olive Oil (4:1 v/v)). Three days after the last exposure, all animals were injected with 3H-methyl thymidine and after five hours the draining (auricular) lymph nodes were excised and pooled for each animal. After precipitating the DNA of the lymph node cells, radioactivity measurements were performed. The activity was expressed as the number of disintegrations per minute (DPM) and a stimulation index (SI) was subsequently calculated for each group.
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: A Stimulation Index (SI) is calculated for each group using the individual SI values. The individual SI is the ratio of the DPM/animal compared to the DPM/vehicle control group mean. If the results indicate a SI ≥ 3, the test item may be regarded as a skin sensitizer. Consideration was given to the EC3 value (the estimated test item concentration that will give a SI =3), EC3 value ≤ 2%: sub-category 1A, EC3 value > 2%: sub-category 1B.
TREATMENT PREPARATION AND ADMINISTRATION:
Test item dosing formulations (w/w) were homogenized in the vehicle (acetone/olive oil (4:1 v/v)) to visually acceptable levels at appropriate concentrations to meet dose level requirements. The dosing formulations were prepared daily and dosed within 4 hours after adding the vehicle to the test item. The dosing formulations were kept at room temperature until dosing. The dorsal surface of both ears was topically treated (25 μL/ear) with the test item, at approximately the same time on each day. The concentrations were stirred with a magnetic stirrer immediately prior to dosing. The control animals were treated in the same way as the experimental animals, except that the vehicle was administered instead of the test item. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- -DPM values are presented for each animal and for each dose group. A Stimulation Index (SI) is calculated for each group using the individual SI values.
-The individual SI is the ratio of the DPM/animal compared to the DPM/vehicle control group mean.
-The EC3 value (the estimated test item concentration that will give a SI =3) was determined, using linear interpolation. - Positive control results:
- The SI values calculated for the item concentrations 1, 2 and 5% were 1.9, 3.7, and 7.3 respectively.
An EC3 value of 19.2% was calculated for the positive control using linear interpolation. The calculated EC3 value was found to be in the acceptable range of 4.8 and 19.5%. The results of the 6 monthly HCA reliability checks of the recent years were 13.2, 14.1, 17.3, 9.8, 17.8%, 18.0%,14.7% and 13.2%. The six-month reliability check with Alpha-hexylcinnamaldehyde indicates that the Local Lymph Node Assay as performed at Charles River Den Bosch was found a appropriate model for testing for contact hypersensitivity. - Key result
- Parameter:
- EC3
- Value:
- 1.6
- Parameter:
- SI
- Value:
- 1
- Variability:
- 0.1
- Test group / Remarks:
- 0%
- Parameter:
- SI
- Value:
- 1.9
- Variability:
- 0.3
- Test group / Remarks:
- 1% dose
- Parameter:
- SI
- Value:
- 3.7
- Variability:
- 0.8
- Test group / Remarks:
- 2% dose
- Parameter:
- SI
- Value:
- 7.3
- Variability:
- 0.9
- Test group / Remarks:
- 5% dose
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
- All auricular lymph nodes of the animals of the experimental and control groups were considered no rmal in size. No macroscopic abnormalities of the surrounding area were noted for any of the animals.
DETAILS ON STIMULATION INDEX CALCULATION
- Mean DPM/animal values for the experimental groups treated with test item concentrations 1, 2 and 5% were 579, 1107 and 2179 DPM, respectively. The mean DPM/animal value for the vehicle control group was 298 DPM. The SI values calculated for the test item concentrations 1, 2 and 5% were 1.9, 3.7 and 7.3 respectively.
EC3 CALCULATION
- The EC3 value (the estimated item concentration that will give a SI=3) was determined based on the dose response relationship or calculated using linear interpolation. The test item elicits a SI ≥ 3 when tested at 2%. The data showed a dose response and an EC3 value of 1.6 was calculated.
CLINICAL OBSERVATIONS:
- The very slight erythema of the ears and/or scaliness for individual test item treated animals throughout the dosing groups between days 4 and 6 was considered not to have a toxicologically significant effect on the activity of the nodes.
-No mortality occurred and no clinical signs of systemic toxicity were observed in the animals of the main study.
BODY WEIGHTS
- Body weights and body weight gain of experimental animals remained in the same range as controls over the study period. - Interpretation of results:
- Category 1A (indication of significant skin sensitising potential) based on GHS criteria
- Remarks:
- based on CLP criteria ( Annex I of 1272/2008/EC)
- Conclusions:
- Based on the results of this study, the calculated EC3 value is 1.6%. Therefore, Gurjun balsam oil (Gurjunene) needs to be classified as category 1A skin sensitiser according to the classification criteria outlined in Annex I of 1272/2008/EC (CLP).
- Executive summary:
The skin sensitisation potential of Gurjun balsam oil (Gurjunene) was tested according to OECDTG 429. Three experimental groups of five female CBA/J mice were treated with 25µL test item concentrations of 1, 2 or 5% w/w on three consecutive days, by open application on the ears. Test item concentrations selected for the main study were based on the results of a prescreen test. Five vehicle control animals were similarly treated, but with the vehicle alone (AcOO). Very slight erythema and/or scaliness was noted was considered not to have a toxicologically significant effect on the activity of the nodes. No mortality occurred and no clinical signs of systemic toxicity were observed in the animals of the main study. All auricular lymph nodes of the animals of the experimental and control groups were considered normal in size. No macroscopic abnormalities of the surrounding area were noted for any of the animals. Body weights and body weight gain of experimental animals remained in the same range as controls over the main study period. Mean DPM/animal values for the experimental groups treated with test item concentrations 1, 2 and 5% were 579, 1107 and 2179 DPM respectively. The mean DPM/animal value for the vehicle control group was 298 DPM. The SI values calculated for the test item concentrations 1, 2 and 5% were 1.9, 3.7 and 7.3 respectively. The data showed a dose-response and an EC3 value (the stimated test item concentration that will give a SI =3) of 1.6% was calculated.Based on these results, Gurjun balsam oil (Gurjunene) needs to be classified as category 1A skin sensitiser according to the classification criteria outlined in Annex I of 1272/2008/EC (CLP).
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Additional information:
Skin sensitization (LLNA)
The skin sensitisation potential of Gurjun balsam oil (Gurjunene) was tested according to OECDTG 429. Three experimental groups of five female CBA/J mice were treated with 25µL test item concentrations of 1, 2 or 5% w/w on three consecutive days, by open application on the ears. Test item concentrations selected for the main study were based on the results of a prescreen test. Five vehicle control animals were similarly treated, but with the vehicle alone (AcOO). Very slight erythema and/or scaliness was noted was considered not to have a toxicologically significant effect on the activity of the nodes. No mortality occurred and no clinical signs of systemic toxicity were observed in the animals of the main study. All auricular lymph nodes of the animals of the experimental and control groups were considered normal in size. No macroscopic abnormalities of the surrounding area were noted for any of the animals. Body weights and body weight gain of experimental animals remained in the same range as controls over the main study period. Mean DPM/animal values for the experimental groups treated with test item concentrations 1, 2 and 5% were 579, 1107 and 2179 DPM respectively. The mean DPM/animal value for the vehicle control group was 298 DPM. The SI values calculated for the test item concentrations 1, 2 and 5% were 1.9, 3.7 and 7.3 respectively. The data showed a dose-response and an EC3 value (the stimated test item concentration that will give a SI =3) of 1.6% was calculated.Based on these results, Gurjun balsam oil (Gurjunene) needs to be classified as category 1A skin sensitiser according to the classification criteria outlined in Annex I of 1272/2008/EC (CLP).
Justification for classification or non-classification
Based on the results of this LLNA study, the calculated EC3 value is 1.6%. Therefore, Gurjun balsam oil (Gurjunene) needs to be classified as category 1A skin sensitiser according to the classification criteria outlined in Annex I of 1272/2008/EC (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.